Peptide mimics of a carbohydrate‑associated epitope expressed by cancer cells: Identification of vaccine candidates

Wen,Liyan; Yang,Sha; Zhu,Ping; Yu,Yingxin; Qiu,Xiaoyan; Fu,Ning; Liu,Yanjun

doi:10.3892/mmr.2016.5863

Peptide mimics of a carbohydrate‑associated epitope expressed by cancer cells: Identification of vaccine candidates

Authors:
- Liyan Wen
- Sha Yang
- Ping Zhu
- Yingxin Yu
- Xiaoyan Qiu
- Ning Fu
- Yanjun Liu
View Affiliations

Affiliations: Department of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R. China
Published online on: October 19, 2016 https://doi.org/10.3892/mmr.2016.5863
Pages: 5237-5244

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer-associated antigen 215 (CA215) is an immunoglobulin molecule expressed by numerous tumor types. Membrane‑bound and soluble CA215 have been detected in the majority of cancer cells and rarely identified in normal tissues. In addition, CA215C is a carbohydrate‑associated epitope in the variable region of CA215, which is specifically recognized by the monoclonal antibody, RP215. However, CA215C is not a suitable vaccine candidate as it is a thymus‑independent antigen. In the present study, RP215 was used as a target to screen short peptide mimics of CA215C from a phage display peptide library. Following three rounds of screening, 30 positive phage clones that specifically bound to RP215 were identified and sequenced. The result of amino‑acid sequence analysis revealed five conserved sequence groups for seventeen of the positive phage clones. The sequences of phage clones 2, 13 and 42 were selected for peptide synthesis and binding analysis. The synthetic peptides R2 and R42 specifically bound RP215. Antisera from mice immunized with R2‑BSA or R42‑BSA bound purified CA215C and innate CA215C expressed on human hepatic and rectal carcinoma tissues, as demonstrated by immunohistochemistry. Furthermore, R2‑BSA and R42‑BSA antisera inhibited RP215 binding to cancer tissues. These results revealed that R2‑BSA and R42‑BSA antisera had similar characteristics to RP215 and that the synthetic peptides R2 and R42 may mimic the CA215C epitope. R2 and R42 peptides may therefore have potential for development into a tumor vaccine.

View Figures

View References

1	Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao P, Li G, Lv P, Li Z, Sun X, et al: Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 63:6488–6495. 2003.PubMed/NCBI
2	Li M, Feng DY, Ren W, Zheng L, Zheng H, Tang M and Cao Y: Expression of immunoglobulin kappa light chain constant region in abnormal human cervical epithelial cells. Int J Biochem Cell Biol. 36:2250–2257. 2004. View Article : Google Scholar : PubMed/NCBI
3	Chen Z, Huang X, Ye J, Pan P, Cao Q, Yang B, Li Z, Su M, Huang C and Gu J: Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer. 116:1953–1963. 2010. View Article : Google Scholar : PubMed/NCBI
4	Lee G, Laflamme E, Chien CH and Ting HH: Molecular identity of a pan cancer marker, CA215. Cancer Biol Ther. 7:2007–2014. 2008. View Article : Google Scholar : PubMed/NCBI
5	Lee G: Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications. Cancer Biomark. 5:137–142. 2009.PubMed/NCBI
6	Lee G and Ge BX: Cancer cell expressions of immunoglobulin heavy chains with unique carbohydrate-associated biomarker. Cancer Biomark. 5:177–188. 2009.PubMed/NCBI
7	Lee G, Ge B, Huang TK, Zheng G, Duan J and Wang IH: Positive identification of CA215 pan cancer biomarker from serum specimens of cancer patients. Cancer Biomark. 6:111–117. 2010.PubMed/NCBI
8	Lee G, Zhu M, Ge B and Potzold S: Widespread expressions of immunoglobulin superfamily proteins in cancer cells. Cancer Immunol Immunother. 61:89–99. 2012. View Article : Google Scholar : PubMed/NCBI
9	Lee G, Cheung AP, Li B, Ge B and Chow PM: Molecular and immuno-characteristics of immunoglobulin-like glycoproteins in cancer cell-expressed biomarker, CA215. Immunol Invest. 41:429–446. 2012. View Article : Google Scholar : PubMed/NCBI
10	Lee G and Ge B: Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies. Cancer Immunol Immunother. 59:1347–1356. 2010. View Article : Google Scholar : PubMed/NCBI
11	Lee G, Chu RA and Ting HH: Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody. Cancer Biol Ther. 8:161–166. 2009. View Article : Google Scholar : PubMed/NCBI
12	Tang L, Zhu P, Luo C, Xu XM and Fu N: Preparation and identification of monoclonal antibodies against different epitopes on human zeta globin chain. Di Yi Jun Yi Da Xue Xue Bao. 25:1394–1397. 2005.(In Chinese). PubMed/NCBI
13	Xiao H, Zhu P, Liu B, Pan Q, Jiang X, Xu X and Fu N: Generation and characterization of human delta-globin-specific monoclonal antibodies. Blood Cells Mol Dis. 44:127–132. 2010. View Article : Google Scholar : PubMed/NCBI
14	Chen Y, Liu B, Yang D, Li X, Wen L, Zhu P and Fu N: Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus. J Med Microbiol. 60:995–1002. 2011. View Article : Google Scholar : PubMed/NCBI
15	Hou XR, Liu BY, Tian JW, Chen YG and Fu N: Screening and Characterization of the Mimotopes of Adveanced Oxidation Protein Products from Phage Peptide Library. Chinese Journal of Laboratory Diagnosis. 15:765–768. 2011.
16	Nagy G and Pál T: Lipopolysaccharide: A tool and target in enterobacterial vaccine development. Biol Chem. 389:513–520. 2008. View Article : Google Scholar : PubMed/NCBI
17	Samuel J, Noujaim AA, MacLean GD, Suresh MR and Longenecker BM: Analysis of human tumor associated Thomsen-Friedenreich antigen. Cancer Res. 50:4801–4808. 1990.PubMed/NCBI
18	Monzavi-Karbassi B, Luo P, Jousheghany F, Torres-Quiñones M, Cunto-Amesty G, Artaud C and Kieber-Emmons T: A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response. Cancer Res. 64:2162–2166. 2004. View Article : Google Scholar : PubMed/NCBI
19	Tiwari R, Negi SS, Braun B, Braun W, Pomés A, Chapman MD, Goldblum RM and Midoro-Horiuti T: Validation of a phage display and computational algorithm by mapping a conformational epitope of Bla g 2. Int Arch Allergy Immunol. 157:323–330. 2012. View Article : Google Scholar : PubMed/NCBI
20	Gazarian KG, Palacios-Rodriguez Y, Gazarian TG and Huerta L: HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: Implications for the epitope structural features. Mol Immunol. 54:148–156. 2013. View Article : Google Scholar : PubMed/NCBI
21	Hossany RB, Johnson MA, Eniade AA and Pinto BM: Synthesis and immunochemical characterization of protein conjugates of carbohydrate and carbohydrate-mimetic peptides as experimental vaccines. Bioorgan Med Chem. 12:3743–3754. 2004. View Article : Google Scholar
22	Lee G and Azadi P: Peptide mapping and glycoanalysis of cancer cell-expressed glycoproteins CA215 recognized by RP215 monoclonal antibody. J Carbohyd Chem. 31:10–30. 2012. View Article : Google Scholar
23	Wu YZ, Zhang JB, Chen SY, Chen A, Wang L, Li J, Zhao T, Zou L, Tang Y, Tingrong L and Wang F: Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers. Immunol Lett. 92:253–258. 2004. View Article : Google Scholar : PubMed/NCBI
24	Yamada A, Sasada T, Noguchi M and Itoh K: Next-generation peptide vaccines for advanced cancer. Cancer Sci. 104:15–21. 2013. View Article : Google Scholar : PubMed/NCBI
25	Cheng WK, Wee K, Kollmann TR and Dutz JP: Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol. 21:329–339. 2014. View Article : Google Scholar : PubMed/NCBI